IDiyas

For the Inventor, By the Inventor

Saint Nom La Breteche, France

Alexander E Wick

USPTO Granted Patents = 16

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 84(Granted Patents)


Location History:

  • Paris, FR (1987)
  • St Nom-De-Breteche, FR (1987)
  • St Nom la Breteche, FR (1987 - 1991)
  • St. Nom La Breteche, FR (1991 - 1996)
  • Saint Nom La Breteche, FR (1984 - 1997)

Company Filing History:

goldMedal16 out of 252 
 
Synthelabo
 patents

Years Active: 1984-1997

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5620990 - Alpha-(4-chlorophenyl)-4-[(4-fluorphenyl)-methyl]piperidine-1-ethanol (1997-04-15),
2. 5589190 - Sustained-release compositions of alfuzosin hydrochloride (1996-12-31),
3. 5523094 - Transdermal pharmaceutical composition (1996-06-04),
4. 5169779 - Process for the preparation of methyl (1992-12-08),
5. 5102998 - Method for preparing (1992-04-07),
6. 5081277 - Process for the preparation of propionic acid derivatives (1992-01-14),
7. 5023266 - Method of treatment of psychotic disorders (1991-06-11),
8. 5013835 - Method of preparing (1991-05-07),
9. 5008434 - Process for the preparation of methyl (1991-04-16),
10. 4690931 - Therapeutically useful 1-phenyl-2-piperidinoalkanol derivatives (1987-09-01),
11. 4663350 - Unsaturated diphenylazomethine derivatives, their preparation and (1987-05-05),
12. 4661498 - Furo 3,2-c pyridine derivatives and their use in treating depression and (1987-04-28),
13. 4638080 - Preparation of diphenylazomethines (1987-01-20),
14. 4621087 - Anti-anoxic furo- or pyrrolo-pyridine compounds and pharmaceutical (1986-11-04),
15. 4515814 - 3-Phenoxypropan-2-ol derivatives for treating glaucoma (1985-05-07),

Title: The Innovative Contributions of Alexander E. Wick

Introduction

Alexander E. Wick is a notable inventor based in Saint Nom La Breteche, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 16 patents. His work focuses on developing innovative compounds and formulations that have therapeutic applications.

Latest Patents

Among his latest patents is the invention of Alpha-(4-chlorophenyl)-4-[(4-fluorphenyl)-methyl]piperidine-1-ethanol. This piperidine derivative is characterized by a specific formula where R can represent various alkyl and alkenyl groups, cycloalkyl groups, or phenyl groups, including their optically pure enantiomers. This invention also details a process for making these compounds and their therapeutic applications. Another significant patent is for sustained-release compositions of alfuzosin hydrochloride. This pharmaceutical composition features a core of alfuzosin hydrochloride coated with a pH-dependent dissolution coating, aimed at creating sustained-release dosage forms suitable for once-daily oral administration.

Career Highlights

Alexander Wick has built a successful career in the pharmaceutical industry, working with Synthelabo, a company known for its innovative drug development. His expertise in creating effective pharmaceutical formulations has positioned him as a key figure in his field.

Collaborations

Throughout his career, Alexander has collaborated with notable colleagues, including Jonathan Reid Frost and Guy Rossey. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Alexander E. Wick's contributions to pharmaceutical innovation are significant, with a focus on developing effective therapeutic compounds. His work continues to impact the field positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…